Literature DB >> 23318345

Duration of in vitro storage affects the key stem cell features of human bone marrow-derived mesenchymal stromal cells for clinical transplantation.

Hoon Sang Sohn1, June Seok Heo, Han-Soo Kim, Youjeong Choi, Hyun Ok Kim.   

Abstract

BACKGROUND AIMS: Mesenchymal stromal cells (MSCs) have the ability to self-renew and differentiate into various cell types. Their plasticity and easy availability make them promising candidates for regenerative medicine. However, for successful clinical application, MSCs need to be expanded under a Good Manufacturing Practices-compliant system to obtain a large quantity of these cells. Although the viability and potency of these in vitro-expanded MSCs need to be maintained during preparation and transportation before transplantation, these characteristics have not thoroughly been examined. Our goal in this study was to standardize MSC preparation and storage before their clinical application to ensure reproducible quality and potency for their clinically intended purpose.
METHODS: We examined the viability, self-renewal capacity and differentiation capability of MSCs on short-term in vitro storage in saline or dextrose solution at 4°C and room temperature.
RESULTS: MSCs harvested and suspended in saline for 1-2 h showed >90% viability regardless of storage temperature. However, when cells were stored for >2 h in saline, their viability decreased gradually over time. The viability of cells in dextrose deteriorated rapidly. MSCs lost colony-forming unit and differentiation capacities rapidly as storage time increased. Collectively, we found that a storage period >2 h resulted in a significant decrease in cell viability, cell proliferation capacity and differentiation potency.
CONCLUSIONS: Storage of culture-harvested MSCs for >2 h is likely to result in suboptimal MSC-mediated tissue regeneration because of decreased cell viability and differentiation capacity.
Copyright © 2013 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23318345     DOI: 10.1016/j.jcyt.2012.10.015

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  23 in total

Review 1.  Into the eyes of bone marrow-derived mesenchymal stem cells therapy for myocardial infarction and other diseases.

Authors:  Jian-Rui Li; Ting-Ting Qu
Journal:  Stem Cell Investig       Date:  2017-08-23

2.  Role of Mesenchymal Stem Cells Densities When Injected as Suspension in Joints with Osteochondral Defects.

Authors:  Elhussein Elbadry Mahmoud; Naosuke Kamei; Goki Kamei; Tomoyuki Nakasa; Ryo Shimizu; Yohei Harada; Nobuo Adachi; Nabil Ahmed Misk; Mitsuo Ochi
Journal:  Cartilage       Date:  2017-05-10       Impact factor: 4.634

3.  Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?

Authors:  Guido Moll; Jessica J Alm; Lindsay C Davies; Lena von Bahr; Nina Heldring; Lillemor Stenbeck-Funke; Osama A Hamad; Robin Hinsch; Lech Ignatowicz; Matthew Locke; Helena Lönnies; John D Lambris; Yuji Teramura; Kristina Nilsson-Ekdahl; Bo Nilsson; Katarina Le Blanc
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

4.  Alginate-Encapsulation for the Improved Hypothermic Preservation of Human Adipose-Derived Stem Cells.

Authors:  Stephen Swioklo; Andrei Constantinescu; Che J Connon
Journal:  Stem Cells Transl Med       Date:  2016-01-29       Impact factor: 6.940

Review 5.  Influence of Hypothermic Storage Fluids on Mesenchymal Stem Cell Stability: A Comprehensive Review and Personal Experience.

Authors:  Aneta Ścieżyńska; Marta Soszyńska; Patrycja Szpak; Natalia Krześniak; Jacek Malejczyk; Ilona Kalaszczyńska
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

6.  Comparison of viability and antioxidant capacity between canine adipose-derived mesenchymal stem cells and heme oxygenase-1-overexpressed cells after freeze-thawing.

Authors:  Mijung Kim; Yongsun Kim; Seunghoon Lee; Minyoung Kuk; Ah Young Kim; Wanhee Kim; Oh-Kyeong Kweon
Journal:  J Vet Med Sci       Date:  2015-12-27       Impact factor: 1.267

7.  Microvesicles from brain-extract-treated mesenchymal stem cells improve neurological functions in a rat model of ischemic stroke.

Authors:  Ji Yong Lee; Eiru Kim; Seong-Mi Choi; Dong-Wook Kim; Kwang Pyo Kim; Insuk Lee; Han-Soo Kim
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

8.  Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue.

Authors:  June Seok Heo; Youjeong Choi; Han-Soo Kim; Hyun Ok Kim
Journal:  Int J Mol Med       Date:  2015-11-19       Impact factor: 4.101

9.  Temporary storage solution for adipose derived mesenchymal stem cells.

Authors:  Chyara Elisa Nofianti; Intan Novita Sari; Jeanne Adiwinata Pawitan
Journal:  Stem Cell Investig       Date:  2018-06-07

10.  Viability of equine mesenchymal stem cells during transport and implantation.

Authors:  Elaine R Garvican; Sandra Cree; Lydia Bull; Roger Kw Smith; Jayesh Dudhia
Journal:  Stem Cell Res Ther       Date:  2014-08-08       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.